In a French multicenter clinical trial on diffuse large B-cell lymphoma, researchers found that patients with high levels of PD-L1 protein have a poorer prognosis, with a 3-year OS of 76% versus 89% in healthy controls [21]. The gene discussed is CD274; the disease is diffuse large B-cell lymphoma.